SCAI Advocacy Highlights

Advocating on behalf of SCAI’s members, the patients we serve, and our profession.

SCAI continued its support for a number of advocacy efforts being spearheaded by the public health community to encourage congressional appropriators to maintain strong Food and Drug Administration (FDA) oversight of tobacco products.

On March 15, 2018, the Medicare Payment Advisory Commission (MedPAC) released its March 2018 Report to the Congress regarding Medicare payment policy. The report includes MedPAC’s recommendations for how Congress should update payment rates in fee-for-service (FFS) Medicare for 2019.

Hart Health Strategies newsletter for the week of February 18th. Now you can also listen to our newsletter through our podcast, Health on the Hill. Subscribe to the podcast in iTunes by clicking here, and you will receive new episodes as they are published. If you have an Android device without iTunes, you can listen to episodes on SoundCloud by clicking here.

SCAI has been closely watching developments regarding a proposed HHS/CMS rule, filed with the Office of Management and Budget on August 10, titled “Cancellation of Advancing Care Coordination through Episode Payment and Cardiac Rehabilitation Incentive Payment Models; Changes to Comprehensive Care for Joint Replacement Payment Model (CMS-5524-P).” Based on the title, it has been anticipated that the mandatory AMI Bundled Program would be canceled. In April, SCAI expressed concerns and recommended revisions to the program that was slated to go into effect January 1, 2018, in a letter to Secretary Price.